$6.0M
+$6.0M this year1 filing since 2026 · latest Equity filed
Genomenon is an Ann Arbor genomic intelligence company that structures biomedical literature into searchable, actionable genomic evidence. Founded in 2014 out of the University of Michigan, it combines AI-driven indexing of millions of full-text articles with expert scientific curation to link genes, variants, diseases, phenotypes and therapies. Its platforms are used by clinical diagnostic laboratories and biopharmaceutical companies, including Mayo Clinic, Quest Diagnostics, Myriad Genetics and the NHS.
What sets it apart
Rather than a general literature search, Genomenon indexes genomic associations at the variant level across more than 10 million full-text articles and layers expert curation on top, so labs get evidence tied to a specific variant instead of a reading list.
A germline variant interpretation platform that surfaces indexed and curated literature evidence for more than 26 million genomic variants, with an AI-powered search integration launched in 2025.
